Teladoc Health, Inc. (NYSE:TDOC) Insider Sells $132,115.59 in Stock

Teladoc Health, Inc. (NYSE:TDOC) insider Laizer Kornwasser sold 10,411 shares of the business’s stock in a transaction dated Thursday, May 2nd. The stock was sold at an average price of $12.69, for a total transaction of $132,115.59. Following the transaction, the insider now owns 86,070 shares in the company, valued at $1,092,228.30. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Laizer Kornwasser also recently made the following trade(s):

• On Friday, February 2nd, Laizer Kornwasser sold 7,882 shares of Teladoc Health stock. The stock was sold at an average price of $19.18, for a total transaction of $151,176.76.

Teladoc Health Stock Up 1.4 %

TDOC traded up $0.18 during trading hours on Thursday, hitting $13.00. 5,025,101 shares of the company’s stock were exchanged, compared to its average volume of 4,835,000. Teladoc Health, Inc. has a 12-month low of $12.53 and a 12-month high of $30.41. The firm has a 50 day moving average of $14.48 and a 200 day moving average of $17.60. The firm has a market cap of $2.20 billion, a P/E ratio of -9.08 and a beta of 0.97. The company has a current ratio of 3.82, a quick ratio of 3.47 and a debt-to-equity ratio of 0.67.

Teladoc Health (NYSE:TDOC) last announced its earnings results on Thursday, April 25th. The health services provider reported ($0.49) earnings per share for the quarter, missing the consensus estimate of ($0.47) by ($0.02). Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.90%. The business had revenue of $646.13 million for the quarter, compared to analysts’ expectations of $637.31 million. During the same period in the previous year, the company earned ($0.37) earnings per share. Teladoc Health’s quarterly revenue was up 2.7% on a year-over-year basis. Analysts predict that Teladoc Health, Inc. will post -1.04 EPS for the current fiscal year.

Institutional Investors Weigh In On Teladoc Health

Large investors have recently added to or reduced their stakes in the business. ICA Group Wealth Management LLC purchased a new stake in shares of Teladoc Health in the 4th quarter valued at approximately $28,000. Hexagon Capital Partners LLC increased its position in shares of Teladoc Health by 204.4% in the 4th quarter. Hexagon Capital Partners LLC now owns 1,586 shares of the health services provider’s stock valued at $34,000 after purchasing an additional 1,065 shares during the last quarter. RIA Advisory Group LLC purchased a new stake in shares of Teladoc Health in the 4th quarter valued at approximately $36,000. GAMMA Investing LLC purchased a new stake in shares of Teladoc Health in the 4th quarter valued at approximately $41,000. Finally, Principal Securities Inc. purchased a new stake in shares of Teladoc Health in the 4th quarter valued at approximately $45,000. 76.82% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities analysts have weighed in on the stock. Piper Sandler decreased their target price on shares of Teladoc Health from $30.00 to $25.00 and set an “overweight” rating on the stock in a report on Wednesday, February 21st. Truist Financial decreased their target price on shares of Teladoc Health from $23.00 to $17.00 and set a “hold” rating on the stock in a report on Wednesday, March 6th. SVB Leerink assumed coverage on shares of Teladoc Health in a report on Monday, February 26th. They issued a “market perform” rating and a $17.00 target price on the stock. DA Davidson decreased their target price on shares of Teladoc Health from $22.00 to $18.00 and set a “neutral” rating on the stock in a report on Wednesday, February 21st. Finally, Wells Fargo & Company decreased their target price on shares of Teladoc Health from $17.00 to $15.00 and set an “equal weight” rating on the stock in a report on Monday. Twelve research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $18.73.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.